Clinical and pathological factors associated with survival in patients with pancreatic cancer who receive adjuvant therapy after neoadjuvant therapy: A retrospective multi-institutional analysis.
Shimizu T, Maeda S, Link J, Deranteriassian A, Premji A, Verma A, Chervu N, Park J, Girgis M, Benharash P, Hines J, Wainberg Z, Wolfgang C, Burns W, Yu J, Fernandez-Del Castillo C, Lillemoe K, Ferrone C, Donahue T.
Shimizu T, et al. Among authors: yu j.
Surgery. 2024 May;175(5):1377-1385. doi: 10.1016/j.surg.2024.01.008. Epub 2024 Feb 16.
Surgery. 2024.
PMID: 38365548